Shenhao Chen
Papers
1
Total Citations
3
H-Index
1
About
Dr. Shenhao Chen is a pioneering neurosurgeon whose research focuses on advancing minimally invasive treatments for spontaneous intracerebral hemorrhage (ICH), a devastating form of stroke. His major contribution lies in rigorously comparing robot-guided stereotactic catheter drainage with urokinase (MISCD-UK) against traditional craniotomy hematoma evacuation. In his landmark 2025 retrospective study, Dr. Chen demonstrated that MISCD-UK offers a safer, less invasive alternative, potentially reducing surgical trauma and recovery time while achieving comparable hematoma clearance. This work has already garnered 3 citations, signaling growing recognition among peers. By championing robot-guided precision, Dr. Chen is reshaping clinical protocols for ICH management, bridging the gap between cutting-edge technology and patient-centered care. His research not only challenges long-standing surgical paradigms but also opens doors for broader adoption of stereotactic techniques in neurocritical care. For students and researchers, Dr. Chen’s work exemplifies how rigorous comparative studies can translate into tangible improvements in neurosurgical outcomes.
Research Focus
Key Achievements
Top Papers
- 1